Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • OREXIGEN THERAPEUTICS INC Financial Overview

  • Income Statement: OREX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 88,000.00 88,000.00 0.00 0.00%
    Gross Profit -359,000.00 -50,000.00 -309,000.00 86.07%
    Net Income Before Extra Items/Preferred Div -93.24 M -57.77 M -35.47 M 38.04%
    Operating Income -94.82 M -60.82 M -34.00 M 35.86%
  • Cash Flow: OREX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 75.79 M 104.25 M -28.46 M -37.55%
    Net Cash Flow - Investing -15.39 M 40.32 M -55.71 M 361.92%
    Net Cash Flow/Operating Activities -74.70 M -54.39 M -20.31 M 27.19%
  • Balance Sheet: OREX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 91.91 M 91.32 M 588,000.00 0.64%
    Total Liabilities 38.11 M 26.44 M 11.68 M 30.64%
    Shareholders Equity 53.79 M 64.88 M -11.09 M -20.61%
  • Key Ratios / Statistics: OREX

    • Valuation

      Price/Earnings (TTM) -2.02
      Price/Sales (TTM) 2,137.93
      Price/Book (MRQ) 5.21
      Price/Cash Flow (TTM) -3.92
    • Profitability

      Gross Margin -407.95
      Operating Margin -107,754.55
      Profit Margin -105,954.55
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 3.25
      Current Ratio (MRQ) 6.16
      Long Term Debt-to-Equity (MRQ) 4.21
    • Management Effectiveness

      Return on Equity (TTM) -139.15
      Return on Assets (TTM) -66.56
      Return on Investments (TTM) -122.28